ArticleCancer medicine2021

Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.

Leo Mascarenhas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.